Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Teva
McKesson
Queensland Health
Boehringer Ingelheim
McKinsey
Mallinckrodt
Julphar
Chubb

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077180

« Back to Dashboard

NDA 077180 describes MOMETASONE FUROATE, which is a drug marketed by Fougera Pharms, G And W Labs, Glenmark Generics, Taro, Tolmar, Perrigo Israel, Perrigo New York, Amneal Pharms, and Apotex Inc, and is included in nineteen NDAs. It is available from thirteen suppliers. Additional details are available on the MOMETASONE FUROATE profile page.

The generic ingredient in MOMETASONE FUROATE is mometasone furoate. There are twenty-nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
Summary for 077180
Tradename:MOMETASONE FUROATE
Applicant:Perrigo Israel
Ingredient:mometasone furoate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Pharmacology for NDA: 077180
Medical Subject Heading (MeSH) Categories for 077180
Suppliers and Packaging for NDA: 077180
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MOMETASONE FUROATE mometasone furoate LOTION;TOPICAL 077180 ANDA Perrigo New York Inc 45802-118 N 45802-118-46
MOMETASONE FUROATE mometasone furoate LOTION;TOPICAL 077180 ANDA Perrigo New York Inc 45802-118 N 45802-118-59

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:LOTION;TOPICALStrength0.1%
Approval Date:Apr 6, 2005TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Deloitte
Medtronic
Julphar
Merck
Accenture
Mallinckrodt
Cerilliant
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.